Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anticancer agent 109

😃Good
Catalog No. T85667Cas No. 2097497-16-8

Anticancer agent 109 (compound 6-15) acts as an inhibitor targeting the Gas6-Axl axis, demonstrating significant anti-cancer properties. This compound suppresses the expression of Gas6, Axl, p-PI3K, and p-AKT in cancer cells, thereby inducing G1 phase arrest and promoting apoptosis of cancer cells. Additionally, Anticancer agent 109 effectively inhibits tumor growth in nude mouse tumor-bearing models [1].

Anticancer agent 109

Anticancer agent 109

😃Good
Catalog No. T85667Cas No. 2097497-16-8
Anticancer agent 109 (compound 6-15) acts as an inhibitor targeting the Gas6-Axl axis, demonstrating significant anti-cancer properties. This compound suppresses the expression of Gas6, Axl, p-PI3K, and p-AKT in cancer cells, thereby inducing G1 phase arrest and promoting apoptosis of cancer cells. Additionally, Anticancer agent 109 effectively inhibits tumor growth in nude mouse tumor-bearing models [1].
Pack SizePriceAvailabilityQuantity
10 mgInquiry10-14 weeks
50 mgInquiry10-14 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Anticancer agent 109 (compound 6-15) acts as an inhibitor targeting the Gas6-Axl axis, demonstrating significant anti-cancer properties. This compound suppresses the expression of Gas6, Axl, p-PI3K, and p-AKT in cancer cells, thereby inducing G1 phase arrest and promoting apoptosis of cancer cells. Additionally, Anticancer agent 109 effectively inhibits tumor growth in nude mouse tumor-bearing models [1].
In vitro
Anticancer Agent 109 (10 μM, 48 hours) inhibits Gas6 and Axl in A549 cells and suppresses Gas6-Axl axis related proteins in PANC-1 cells, induces G1 phase arrest, and promotes late apoptosis without altering DNA synthesis [1]. Cell viability assays [1] on cell lines including MCF-7, PANC-1, MDA-MB-231, HT-29, DU145, U937, and A549 with a concentration of 30 μM for 48 hours show inhibition of cancer cell growth with up to 20-fold less toxicity to normal cells and up to 5.4 times higher anticancer activity compared to Sunitinib. Growth inhibition IC50 values are 2.0 μM (MCF-7), 2.8 μM (MDA-MB-231), 4.6 μM (HT-29), 1.1 μM (DU145), 6.7 μM (U937), 4.2 μM (A549), and 4.0 μM (PANC-1). Apoptosis analysis [1] in PANC-1 at concentrations of 1 μM, 5 μM, and 10 μM for 48 hours increases sub-G1 fraction and induces late apoptosis. Western Blot analysis [1] at a concentration of 10 μM for 48 hours in A549 and PANC-1 cells demonstrates inhibition of Gas6 and Axl, increased Bax/Bcl-2 expression ratio, and suppression of p-PI3K and p-AKT in PANC-1 cells. RT-PCR [1] on PANC-1 at concentrations of 3 μM, 5 μM, and 10 μM for 48 hours also confirms inhibition of Gas6 and Axl.
In vivo
Anticancer agent 109, when administered at 3 mg/kg via intraperitoneal injection (i.p.) six times a week, significantly reduced the size and weight of tumors in xenograft models using BALB/c-nu mice, particularly in A549 tumors over 31 days and PANC-1 tumors over 85 days [1]. The dosage of 1 mg/kg resulted in approximately 75% tumor reduction in A549 models, while 3 mg/kg achieved similar outcomes in PANC-1 models, although tumors were not completely eradicated in the A549 models.
Chemical Properties
Molecular Weight317.34
FormulaC19H15N3O2
Cas No.2097497-16-8
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anticancer agent 109 | purchase Anticancer agent 109 | Anticancer agent 109 cost | order Anticancer agent 109 | Anticancer agent 109 chemical structure | Anticancer agent 109 in vivo | Anticancer agent 109 in vitro | Anticancer agent 109 formula | Anticancer agent 109 molecular weight